Procter & Gamble Health Ltd - 500126 - Shareholding for the Period Ended December 31, 2019
Procter & Gamble Health Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agent, Karvy Fintech Private Limited about the issue of duplicate share certificates as detailed in the attachment. Procter & Gamble Health Ltd - 500126 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Flavia MachadoDesignation :- Authorised Signatory Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from January 1, 2020 to February 9, 2020 (both days inclusive). Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Meeting Scheduled To Be Held On February 7, 2020
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 ,inter alia, to consider and approve the unaudited financial results for the quarter ended December 31, 2019.
AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer
The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer. Procter & Gamble Health Ltd - 500126 - Intimation Of Change Of Financial Year Of The Company
We would like to inform you that, the Company has received the approval from the Regional Director, Western Region, Ministry of Corporate Affairs, Mumbai vide its order dated December 18, 2019 read with corrigendum dated December 23, 2019 for change of Financial Year end from 1st January-3151 December to ''1st July-30th June''. A copy of the said order dated December 18, 2019 along with corrigendum dated December 23, 2019 is enclosed. Pursuant to the said approval, the current Financial year of the Company will be for a period of 18 months, starting from 1st January, 2019 to 30th June, 2020 and first financial year post change will begin from 1st July, 2020. Accordingly, the Company will submit Unaudited Financial Results for the quarter ended December 31, 2019. We request you to take the same on record. Procter & Gamble Health Ltd - 500126 - Change Of Name Of Registrar And Share Transfer Agent (RTA)
We have been informed by our Registrar and Share Transfer Agent (''RTA'') that their name has changed from "KARVY FINTECH PRIVATE LIMITED" to "KFIN TECHNOLOGIES PRIVATE LIMITED" effective December 5, 2019. We request you to take the same on record Procter & Gamble Health Ltd - 500126 - Updation Of Company''s Shareholder Helpline Number
We would like to inform that the Company has activated helpline number for Shareholders of the Company, which is given below: Shareholder Helpline number: +918291902520 We request you to take the same on record and update the same on the website of the Stock Exchange. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by the shareholder, about the loss /misplacement of the share certificate as detailed in the attachment.